Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma
Clinical trial NCT02945319 · COMPLETED
Trial details
- NCT number
- NCT02945319
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-12-01
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.